Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Therapeutic effects of extinction require hippocampal input and BDNF signaling in IL
    Published on 2024-07-31
    11 months ago
  • Punishment-resistant alcohol intake is mediated by the nucleus accumbens shell in female rats
    Published on 2024-07-29
    12 months ago
  • Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants
    Published on 2024-07-26
    12 months ago
  • Human neuroimaging and antipsychotic neurobiology at millisecond temporal resolution
    Published on 2024-07-26
    12 months ago
  • Neuroimaging and suicide-specific stimuli
    Published on 2024-07-24
    12 months ago
  • A novel fluorescently labelled ligand for the detection of DAT in immune cells by flow cytometry
    Published on 2024-07-24
    12 months ago
  • Sex differences in sensitivity to dopamine receptor manipulations of risk-based decision making in rats
    Published on 2024-07-23
    12 months ago
« Previous 1 … 32 33 34 35 36 … 143 Next »
Journal of Psychopharmacology
  • Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis
    Published on 2023-09-23
    2 years ago
  • Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study
    Published on 2023-09-19
    2 years ago
  • Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models
    Published on 2023-09-12
    2 years ago
  • Psilocybin history, action and reaction: A narrative clinical review
    Published on 2023-08-31
    2 years ago
  • Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase
    Published on 2023-08-18
    2 years ago
  • Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study
    Published on 2023-08-17
    2 years ago
  • The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
    Published on 2023-08-12
    2 years ago
« Previous 1 … 32 33 34 35 36 … 124 Next »
European Neuropsychopharmacology
  • Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons
    Published on 2023-11-05
    2 years ago
  • Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study
    Published on 2023-10-31
    2 years ago
  • Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia
    Published on 2023-10-21
    2 years ago
  • Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality
    Published on 2023-10-20
    2 years ago
  • Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients
    Published on 2023-10-20
    2 years ago
  • Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis
    Published on 2023-10-20
    2 years ago
  • Methodological concerns in psychedelic research: The issues of nonequivalent psychological support and generalizability
    Published on 2023-10-20
    2 years ago
« Previous 1 … 32 33 34 35 36 … 144 Next »

   Pharma Pub